Acquired resistance to anti-pd1 therapy: checkmate to checkpoint blockade?

HIGHLIGHTS

  • who: Jake S. O’Donnell from the (UNIVERSITY) have published the paper: Acquired resistance to anti-PD1 therapy: checkmate to checkpoint blockade?, in the Journal: (JOURNAL)
  • what: From this study demonstrated that mutations which affected the sensitivity of tumor cells to T-cell-derived interferons, and mutations limiting tumor-cell antigen presentation, could cause acquired resistance.

SUMMARY

    O'Donnell et_al Genome Medicine 8:111 DOI 10.1186/s13073-016-0365-1 COMMENT Open Access Acquired resistance to anti-PD1 therapy: checkmate to checkpoint blockade? A recent study sought to identify mutations . . .

     

    Logo ScioWire Beta black

    If you want to have access to all the content you need to log in!

    Thanks :)

    If you don't have an account, you can create one here.

     

Scroll to Top

Add A Knowledge Base Question !

+ = Verify Human or Spambot ?